Bayer diabetes business sale not imminent: Reuters
German drugmaker Bayer is in talks to sell its diabetes devices division but a sale is not imminent, two sources with knowledge of the matter told Reuters.
20 February 2015•2 mins read
German drugmaker Bayer is in talks to sell its diabetes devices division but a sale is not imminent, two sources with knowledge of the matter told Reuters.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
6 November 2026 · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
6 November 2026 · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
6 November 2026 · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
6 November 2026 · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
6 November 2026 · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
6 November 2026 · 1 min read
PE targets identity security as AI transforms threats: 6 deals
6 November 2026 · 3 mins read
